Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT03381300

Preservation of Ovarian Cortex Tissue in Girls With Turner Syndrome

Rationale: Infertility due is a major concern for girls with Turner syndrome (TS) and their parents. Physicians are often asked about possible options to preserve their fertility. However, despite some experimental case reports, clear evidence for fertility preservation in these girls is lacking and many questions remain. Without evidence on the effectiveness of fertility preservation it cannot routinely be offered to girls with TS.

Objective: To investigate the occurrence of live birth in women with TS after ovarian tissue cryopreservation in childhood followed by auto transplantation in adulthood.

Study design: A national multicentre exploratory intervention study

Study population: Girls diagnosed with Turner Syndrome, aged 2-18 years.

Intervention: Ovarian tissue cryopreservation in childhood followed by auto transplantation in adulthood. In order to obtain the ovarian tissue for cryopreservation, all girls must undergo a laparoscopy under general anaesthesia which will be performed in academic/university clinics with paediatric surgery. During the laparoscopic intervention, a unilateral oophorectomy will be performed, thereby leaving the other ovary intact for hormone production, ovulation, spontaneous pregnancies and as an auto transplantation site for cryopreserved-thawed ovarian cortical tissue later on. Furthermore, a small sample of the ovarian cortex will be used to assess the oocyte quality and genetics (e.g. the presence of germ line mosaicism). Oocytes will be karyotyped by using Fluorescence in situ hybridization (FISH). Karyotypic and hormonal data will be collected once at the yearly clinical visit at the paediatric-endocrinologist. Therefore, a buccal swab and one extra blood sample will be taken and evaluated during the routine laboratory evaluation.

In the future, auto transplantation of frozen-thawed ovarian cortex strips will be performed.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

About this study

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:

The primary objective remains to preserve the fertility of the respective (minor) patient, facing a very high risk of premature ovarian insufficiency (POI) of 95-98%. Disadvantages of participating in this study are the potential risk of complications related to the laparoscopic unilateral oophorectomy and/or the unknown effect on future fertility of these girls. Moreover, the procedure might raise false hope in patients (and/or parents) about the chance of getting pregnant after auto transplantation of cryopreserved-thawed ovarian tissue in the future. However, we attempt to overcome this by extensive and objective information provision by both written materials and face to face counselling.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

  • Girls and young females with classic Turner (i.e. 45X monosomy) or Turner variants (e.g. 45X / 46XX mosaicism, ring X mosaicism, isochromosome X),
  • Aged 2 through 18 years,
  • who completed the diagnostic work up phase of TS including routine cardiac screening*,
  • whose agreement to participate in this study has been signed by the parents (girls 2-11 years old),
  • whose agreement to participate in this study has been signed by the patient and her parents (girls 12-17 years old),
  • whose agreement to participate in this study has been signed by the patient (adolescents of 18 years old).

Exclusion criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:

  • Contra-indications for laparoscopic unilateral oophorectomy under general anaesthesia (e.g. severe cardiovascular comorbidity and/or BMI >40 kg/m2)*,
  • Contra-indications for cryopreservation (i.e. active HIV, hepatitis-B or hepatitis-C infection)
  • Based on the international Cincinnati Turner Guideline consensus Meeting, July 2016 and consultation of Dutch cardiologists, paediatric-cardiologists and anaesthesists between 2016-2017 there are no absolute cardiovascular contra-indications for surgical intervention and/or pregnancy. Advice against surgical intervention and/or pregnancy should be based on the patient-specific cardiovascular risk profile. The 2% mortality risk due to acute aortic dissection is based on one survey and literature review study that reported the outcomes of 101 pregnancies in patients with TS after oocyte donation. Only 50% of the patients were screened by a cardiologist before entering the oocyte donation programme. Therefore, all girls who want to participate in this study should have completed the diagnostic work up phase of TS including routine cardiac screening and will be screened by a paediatric anaesthesist. Exclusion will be based on the patient specific risk profile. See: References.

Treatment and study plan

Ovarian tissue cryopreservation

Procedure

Laparoscopic unilateral oophorectomy followed by cryopreservation of ovarian cortex tissue

Primary outcomes

  1. Live birth ratio (LBR) (main outcome)

    Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue, and up to 45 years after ovarian tissue cryopreservation.

    • Live birth after auto transplantation of cryopreserved-thawed ovarian cortical tissue (i.e. live birth rate or LBR)
  2. Number of primordial follicles (proximate)

    Time frame: Within 1 month after ovarian tissue cryopreservation

    The number of primordial follicles found in the ovarian tissue

Secondary outcomes

  1. Patient's age versus LBR

    Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue, and up to 45 years after ovarian tissue cryopreservation.

    The association between patient's age at cryopreservation and LBR

  2. Patient's genotype versus LBR

    Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue, and up to 45 years after ovarian tissue cryopreservation.

    The association between patient's genotype and LBR

  3. Patient's Anti-Müllerian hormone (AMH) level versus LBR

    Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue, and up to 45 years after ovarian tissue cryopreservation.

    The association between patient's AMH level at cryopreservation and LBR

  4. Patient's Follicle-stimulating hormone (FSH) level versus LBR

    Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue, and up to 45 years after ovarian tissue cryopreservation.

    The association between patient's FSH level at cryopreservation and LBR

Other outcomes

  1. Study participation rate

    Time frame: Up to 3 years after inclusion

    The willingness of girls with TS to perform a unilateral oophorectomy for fertility preservation (i.e. the study participation rate)

  2. Eligible participants

    Time frame: Up to 3 years after inclusion

    The number of eligible participants

  3. Age

    Time frame: Up to 3 years after inclusion

    The age of the participant

  4. Buccal cells versus peripheral lymphocytes

    Time frame: Up to 3 years after inclusion

    The incidence of somatic mosaicism (i.e. buccal cells versus peripheral lymphocytes)

  5. Ovarian cells versus peripheral lymphocytes

    Time frame: Up to 3 years after inclusion

    The incidence of germ cell mosaicism (i.e. ovarian cells versus peripheral lymphocytes and buccal cells)

  6. Serum hormone levels

    Time frame: Up to 3 years after inclusion

    Serum hormone levels (i.e. FSH, Luteinizing hormone (LH), AMH, E2, inhibin B)

  7. Complication rate

    Time frame: Up to 1 year after the laparoscopic procedure

    The number of complications related to the laparoscopic procedure

  8. Influence of laparoscopic oophorectomy on puberty and/or menarche

    Time frame: Up to 10 years after the laparoscopic procedure

    The incidence of puberty and/or menarche after laparoscopic oophorectomy

  9. Incidence of spontaneous pregnancies

    Time frame: Up to 45 years after the laparoscopic procedure

    The incidence of spontaneous pregnancies after laparoscopic oophorectomy

  10. Restoration of ovarian function after auto transplantation of ovarian tissue

    Time frame: Up to 2 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue

    The incidence of menstruation cycle recovery after auto transplantation of cryopreserved-thawed ovarian tissue in the future

  11. Pregnancies after auto transplantation of ovarian tissue

    Time frame: Up to 2 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue

    The incidence of pregnancies after auto transplantation of cryopreserved-thawed ovarian tissue in the future

  12. Ongoing pregnancies after auto transplantation of ovarian tissue

    Time frame: Up to 2 years and 3 months after auto transplantation of cryopreserved-thawed ovarian cortical tissue

    The incidence of ongoing pregnancies after auto transplantation of cryopreserved-thawed ovarian tissue in the future

  13. Miscarriages after auto transplantation of ovarian tissue

    Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue

    The number of miscarriages after auto transplantation of cryopreserved-thawed ovarian tissue in the future

  14. Time to pregnancy after auto transplantation of ovarian tissue

    Time frame: Up to 2 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue

    Time to pregnancy after auto transplantation of cryopreserved-thawed ovarian tissue in the future

  15. Time to live birth after auto transplantation of ovarian tissue

    Time frame: Up to 3 years after auto transplantation of cryopreserved-thawed ovarian cortical tissue

    Time to live birth after auto transplantation of cryopreserved-thawed ovarian tissue in the future

Sponsors and collaborators

Lead sponsor

Radboud University Medical Center

Other

Registry information

Important dates

Study start
2018
Primary completion
2071
Study completion
2071
First posted
Dec 21, 2017
Registry last updated
Feb 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.